English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NA /

KARYOPHARM-RWE

Treatment Patterns And Adverse Event Management In Patients Treated With Selinexor In Combination With Other Approved Agents For Relapsed/Refractory Multiple Myeloma: Real-World Evidence Based On Electronic Medical Record Data

DISEASE GROUP:
Multiple Myeloma
current phase:
NA
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: